| Baseline CRP |  | |
---|---|---|---|
Median (IQR) | |||
Age category | Age <16 | 16 (4–48) | p < 0.001* |
Age 16–35 | 40 (11–93) | ||
Age 35–50 | 50 (14–107) | ||
Age >50 | 39 (13–98) | ||
Gender male | Male | 51 (15–109) | p < 0.001** |
Female | 32 (11–78) | ||
Ethnicity | White | 50 (16–107) | p < 0.001* |
Black African/Caribbean | 49 (16–103) | ||
Asian | 20 (7–54) | ||
Eastern Mediterranean and North Africa | 51 (17–112) | ||
Americas | 65 (28–109) | ||
HIV status | HIV negative | 37 (10–88) | p < 0.001* |
HIV positive | 75 (26–136) | ||
HIV status unknown | 35 (11–86) | ||
Smear status | Smear negative | 28 (7–74) | p < 0.001** |
Smear positive | 66 (30–121) | ||
Culture result | Culture negative | 19 (5–72) | p < 0.001** |
culture positive | 49 (16–103) | ||
Site of disease | Pulmonary or mediastinal lymph node | 47 (14–100) | p < 0.001* |
Pleural or pericardial | 84 (36–132) | ||
Abdominal | 65 (29–124) | ||
Miliary/disseminated | 61 (26–125) | ||
Bone and joint | 33 (10–78) | ||
Peripheral lymph node | 14 (4–41) | ||
Skin and soft tissue | 11 (1–61) | ||
CNS | 13 (4–31) | ||
Other./unknown | 33 (12–76) |